Últimas noticias sobre Reinsurance Gr (NYSE:RGA) Bolsa

Reinsurance Gr

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

Reinsurance Group of America, Incorporated Common Stock

Reinsurance Group of America Inc

Rocket Global Acquisition Corp

<p>Across the recent three months, 12 analysts have shared their insights on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $240.0, a high estimate of $255.00, and a low estimate of $220.00. This current average has increased by 5.26% from the previous average price target of $228.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1728594037_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Reinsurance Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$244.00</td>
<td>$239.00</td>
</tr>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$235.00</td>
<td>-</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$250.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$222.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$242.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Wilma Burdis</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$250.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$236.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$239.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Mark Dwelle</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$220.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$252.00</td>
<td>$194.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reinsurance Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Reinsurance Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Reinsurance Gr's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/RGA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Reinsurance Gr analyst ratings.</strong></a></p>
<h2>All You Need to Know About Reinsurance Gr</h2>
<p>Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.</p>
<h3>Reinsurance Gr's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Reinsurance Gr showcased positive performance, achieving a revenue growth rate of <strong>17.4%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Reinsurance Gr's net margin is impressive, surpassing industry averages. With a net margin of <strong>4.18%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Reinsurance Gr's ROE excels beyond industry benchmarks, reaching <strong>2.11%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Reinsurance Gr's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.19%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.52</strong>, caution is advised due to increased financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

Deep Dive Into Reinsurance Gr Stock: Analyst Perspectives (12 Ratings)

<p>Wells Fargo  analyst Elyse Greenspan   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $239 to $244.</p>


News

Price Target

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $244

<p>TD Cowen  analyst Andrew Kligerman   initiates coverage on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Hold rating and announces Price Target of $235.</p>


Initiation

TD Cowen Initiates Coverage On Reinsurance Gr with Hold Rating, Announces Price Target of $235

WIIM

ACGL

ACIC

CINF

ERIE

FIHL

HRTG

KNSL

PLMR

SPNT

Shares of insurance companies are trading lower while Floridians experience evacuation orders as Category 5 Hurricane Milton approaches the state. The region is still recovering from damage due to Hurricane Helene.

<p>JP Morgan  analyst Jimmy Bhullar   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Neutral and raises the price target from $220 to $222.</p>


JP Morgan Maintains Neutral on Reinsurance Gr, Raises Price Target to $222

<p>Piper Sandler  analyst John Barnidge   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $237 to $242.</p>


Piper Sandler Maintains Overweight on Reinsurance Gr, Raises Price Target to $242

<p><strong>Reinsurance Group of America</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) shares have rallied 35.1% year to date (YTD) compared with the industry&#39;s growth of 21.5%. The Finance sector and the Zacks S&amp;P 500 index have returned 14.3% and 20% YTD, respectively. With a market capitalization of $14.39 billion, the average volume of shares traded in the last three months was 0.3 million.</p>
<h2>RGA Outperforms Industry, Sector, S&amp;P YTD</h2>
<p><img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/01/79471.jpg?v=1113732845" /></p>
<p>Image Source: Zacks Investment Research</p>
<p>The rally was driven by its strong momentum in U.S. Traditional, Longevity/PRT, Asia Asset-Intensive and Asia Traditional, along with solid growth projections.</p>
<p>RGA has a VGM Score of A. VGM Score helps identify stocks with the most attractive value, best growth and the most promising momentum.</p>
<h2>RGA Trading Above 50-Day and 200-Day Moving Average</h2>
<p>This Zacks Rank #3 (Hold) insurance broker closed at $218.58 on Thursday, above its 50-day and 200-day simple moving average&nbsp;of $213.23 and $193.40, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.</p>
<h2>Reinsurance Group&#39;s Earnings Surprise History</h2>
<p>Reinsurance Group has a decent earnings surprise history. Its earnings beat estimates in each of the last four quarters with an average surprise of 20.51%.</p>
<h2>RGA&#39;s Growth Projection Encourages</h2>
<p>The Zacks Consensus Estimate for Reinsurance Group&#39;s 2024 earnings per share indicates a year-over-year increase of 9.1%. The consensus estimate for revenues is pegged at $21.85 billion, implying a year-over-year improvement of 14.7%.</p>
<p>The consensus estimate for 2025 earnings per share indicates a year-over-year increase of 3.4% from the corresponding 2024 estimates.</p>
<p>The expected long-term earnings growth rate is 10.4%, outperforming the industry average of 4.6%. RGA has an impressive Growth Score of B. This style score helps analyze the growth prospects of a company.</p>
<h2>Reinsurance Group&#39;s Return on Invested Capital</h2>
<p>Its return on invested capital has increased every year. This reflects RGA&#39;s efficiency in utilizing funds to generate income. ROIC in the trailing 12 months was 6.8%, higher than the industry average of 0.6%.</p>
<h2>Optimistic Analyst Sentiment for RGA</h2>
<p>Each of the five analysts covering the stock has raised estimates for 2024, and four analysts have raised the same for 2025 over the past 60 days. The consensus estimate for 2024 and 2025 has moved 2.8% and 1.9% north, respectively, in the past 60 days.</p>
<h2>RGA&#39;s Expensive Valuation</h2>
<p>The stock is undervalued compared to its industry. It is currently trading at a price-to-book multiple of 1.46, lower than the industry average of 1.96.</p>
<h2>Will RGA&#39;s Rally Stay?</h2>
<p>Reinsurance Group is a leader in the U.S. and Latin American traditional markets. It has successfully expanded its product line with market-leading services, capabilities, expertise and innovation. Individual mortality has matured and provides a base for stable earnings and capital generation.<br />
Significant value embedded in the in-force business is anticipated to generate predictable long-term earnings. Product-line expansion contributes to risk diversification.</p>
<p>In Canada, Reinsurance Group is a market leader with solid growth and profitability. It has a sizable block of in-force business, which acts as a significant source of future earnings. Reinsurance Group expects longevity insurance, which is projected to witness steady demand, to experience long-term growth in the Canadian market. While longevity insurance provides a source of diversified income, it also acts as a hedge to a large mortality position.</p>
<p>Demand for protection products among the emerging global middle class and increasing demand for retirement, senior protection and savings products among aging populations create opportunities for growth in new business.</p>
<p>RGA is well-capitalized and has access to multiple forms of capital. RGA expects to remain active in deploying capital in attractive growth opportunities while balancing returning excess capital to shareholders over time.</p>
<p>RGA continues to ramp up technological inclusion with its product. This insurer is a global biometric liability reinsurance leader. Biometrics experience, which includes mortality, morbidity and longevity, over the last five quarters was favorable. Notably, its free cash flow conversion has remained more than 85% over the last many quarters, reflecting its solid earnings.</p>
<h2>Wealth Distribution</h2>
<p>This global reinsurer has also been managing capital effectively via share buybacks, dividend payments and prudent investments. RGA expects to remain active in deploying capital into attractive growth opportunities in organic flow and in-force block transactions and returning excess capital to shareholders through dividends and share repurchases. The company exited the second quarter of 2024 with excess capital of around $1 billion, reflecting a solid capital position.</p>
<h2>Key Picks</h2>
<p>Investors interested in the life insurance industry may look at some better-ranked players like <strong>Baldwin Insurance Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwin#NASDAQ">BWIN</a>), <strong>Brighthouse Financial, Inc</strong>. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhf#NASDAQ">BHF</a>) and <strong>Primerica, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pri#NYSE">PRI</a>), each carrying a Zacks Rank #2 (Buy) at present.</p>
<p>The Zacks Consensus Estimate for Baldwin Insurance&#39;s 2024 and 2025 earnings implies year-over-year growth of 38.3% and 32.2%, respectively. BWIN beat earnings estimates in each of the past four quarters, with an average surprise of 11.88%. Year to date, shares of BWIN have gained 108.4%.</p>
<p>The Zacks Consensus Estimate for Brighthouse Financial&#39;s 2024 and 2025 earnings implies year-over-year growth of 29.8% and 9.1%, respectively. It beat earnings estimates in three of the past four quarters while missing in one, with an average surprise of 3.76%. Year to date, shares of BHF have lost 16.3%.</p>
<p>The Zacks Consensus Estimate for Primerica&#39;s 2024 and 2025 earnings implies year-over-year growth of 12.2% and 10.9%, respectively. It beat earnings estimates in two of the past four quarters and missed in two, with an average surprise of 1.74%. Year to date, shares of PRI have climbed 29.6%.</p>
<p><a href="https://www.zacks.com/stock/news/2342526/reinsurance-group-rallies-35-1-ytd-what-s-driving-the-stock?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2342526">To read this article on Zacks.com click here.</a></p>


Earnings

Earnings Beats

Large Cap

Mid Cap

Dividends

Health Care

Small Cap

Markets

Trading Ideas

Insurance

General

Brighthouse Financial, Inc. - Common Stock

BWIN

Reinsurance Group Rallies 35.1% YTD: What's Driving the Stock?

<p>During the last three months, 12 analysts shared their evaluations of Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $221.5, a high estimate of $255.00, and a low estimate of $64.00. Witnessing a positive shift, the current average has risen by 7.29% from the previous average price target of $206.45.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727204428_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Reinsurance Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Wilma Burdis</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$250.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$236.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$239.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Mark Dwelle</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$220.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$252.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$217.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$208.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$247.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$228.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reinsurance Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Reinsurance Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Reinsurance Gr's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/RGA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Reinsurance Gr analyst ratings.</strong></a></p>
<h2>Delving into Reinsurance Gr's Background</h2>
<p>Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.</p>
<h3>Financial Milestones: Reinsurance Gr's Journey</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Reinsurance Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>17.4%</strong> as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Reinsurance Gr's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>4.18%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Reinsurance Gr's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.11%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Reinsurance Gr's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.19%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Reinsurance Gr's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.52</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Cracking The Code: Understanding Analyst Reviews For Reinsurance Gr

<p>Raymond James  analyst Wilma Burdis   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Strong Buy and raises the price target from $228 to $250.</p>


Raymond James Maintains Strong Buy on Reinsurance Gr, Raises Price Target to $250

<p>Barclays  analyst Alex Scott   initiates coverage on Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight rating and announces Price Target of $255.</p>


Barclays Initiates Coverage On Reinsurance Gr with Overweight Rating, Announces Price Target of $255

<p><strong>Reinsurance Gr's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) short percent of float has fallen 18.84% since its last report. The company recently reported that it has <strong>281 thousand shares sold short</strong>, which is 0.56% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.0 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Reinsurance Gr Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1725390021_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Reinsurance Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Reinsurance Gr's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Reinsurance Gr's peer group average for short interest as a percentage of float is 1.93%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

(RGA) - Analyzing Reinsurance Gr's Short Interest

<p>Morgan Stanley  analyst Nigel Dally   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Equal-Weight and lowers the price target from $238 to $236.</p>


Morgan Stanley Maintains Equal-Weight on Reinsurance Gr, Lowers Price Target to $236

<p><strong>Sun Life Financial </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slf#NYSE">SLF</a>) has been benefiting from its focus on Asia operations, growing asset management businesses and the scale-up and integration of U.S. operations. Earnings of SLF have risen 5.4% over the last five years.</p>
<p>This third-largest insurer in Canada has a decent earnings surprise history. It surpassed estimates in three of the last four quarters and missed in one, the average earnings surprise being 1.76%.</p>
<p>Sun Life&#39;s focus on the emerging economies of Asia that are expected to provide higher returns and the North American markets bodes well for long-term growth. SLF has a strong presence in China, Philippines, India, Hong Kong and Indonesia and has also forayed into Malaysia and Vietnam. Contribution from Asia business to Sun Life&#39;s earnings has increased to 21% over the last few years.</p>
<p>Sun Life envisions being one of the top five players and remains focused on growing its voluntary benefits business. The life insurer is also improving its business mix and is thus shifting its growth focus toward products that block lower capital and offer more predictable earnings.</p>
<p>Sun Life Investment Management makes investments in private fixed-income mortgages and real estate. It invests in pension plans and other institutional investors. These are indicative of SLF&#39;s efforts to strengthen Asset Management, which provides a higher return on equity, requires lower capital and sees lesser volatility and has the potential for an earnings upside.</p>
<p>Operational efficiency has been aiding Sun Life in building a strong capital position. The life insurer&#39;s capital outlay includes a 40-50% dividend payout over the medium term.</p>
<p>However, expenses have increased at Sun Life over the past few years due to high employee expenses, premises and equipment, service fees, amortization of intangible assets and other expenses. These, in turn, weigh on margin expansion. The life insurer remains committed toward balancing both metrics, failing which, the bottom line might suffer. The company estimates integration activities to drive run-rate cost savings of $60 million by 2024.</p>
<p>Nonetheless, SLF&#39;s trailing 12-month return on equity was 17.5%, ahead of the industry average of 15.5%. Return on equity, a profitability measure, reflects how effectively a company is utilizing its shareholders&#39; funds. Given the company&#39;s ongoing shift to fee-based capital-light businesses, SLF reiterated its medium-term ROE target of 18%.</p>
<p>Also, the return on invested capital in the trailing 12 months was 0.8%, better than the industry average of 0.7%. This reflects SLF&#39;s efficiency in utilizing funds to generate income.&nbsp;</p>
<h3>Some Key Industry Players</h3>
<p>Other players in the insurance industry are <strong>Brighthouse Financial </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhf#NASDAQ">BHF</a>), <strong>Reinsurance Group of America, Incorporated </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) and <strong>Primerica </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pri#NYSE">PRI</a>).</p>
<p>Brighthouse Financial&#39;s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 3.76%.</p>
<p>With an expansive and compelling suite of life and annuity products and a strong market presence, BHF aims to become a premier player in the individual insurance market.&nbsp; Brighthouse is also revamping its life insurance business to boost annuity sales. Sales of Shield Level annuities and variable annuities with FlexChoice Access should drive Annuity sales.&nbsp; The insurer remains focused on transitioning the business mix to less capital-intensive products.</p>
<p>Reinsurance Group&#39;s earnings surpassed estimates in each of the last four quarters, the average surprise being 20.51%.</p>
<p>RGA has been benefiting from an increase in new business volumes, favorable longevity experience, a stronger invested asset base, business expansion in the pension risk transfer market and effective capital deployment.</p>
<p>Primerica&#39;s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 1.74%.</p>
<p>This second-largest issuer of term-life insurance coverage in North America aims to be a successful senior health business while continuing to enhance its shareholders&#39; value. Strong demand for protection products drives sales growth and policy persistency benefit the life insurer. A strong business model makes Primerica well-poised to cater to the middle market&#39;s increased demand for financial security.</p>
<p><a href="https://www.zacks.com/stock/news/2322684/sun-life-slf-grows-on-solid-asia-business-amid-cost-woes?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2322684">To read this article on Zacks.com click here.</a></p>


Asia

Management

Sun Life Grows on Solid Asia Business Amid Cost Woes

<p><strong>Sun Life Financial Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slf#NYSE">SLF</a>) delivered second-quarter 2024 underlying net income of $1.25 per share, which beat the Zacks Consensus Estimate by 5.9%. The bottom line increased 6.8% year over year. Underlying net income was $730.8 million (C$1 billion), which increased 9% year over year.</p>
<p>Results reflected continued solid growth in Canada and Asia. The U.S. also saw favorable experience in Group Benefits, partially offset by residual headwinds in dental.</p>
<p>Revenues of $6.5 billion increased 14.2% year over year but missed the Zacks Consensus Estimate by 3%.</p>
<p>Wealth sales &amp; asset management gross flows of $33.8 billion (C$46.3 billion) increased 9.1% year over year. Group - Health &amp; Protection sales of $362.5 million (C$496 million) decreased 17.7% year over year. Individual - Protection sales of $550.3 million (C$753 million) jumped 24.7% year over year.</p>
<p>New business contractual service margin was $319.4 million (C$437 million), up 61.9% year over year.</p>
<div class="chart_embed">
<h3>Sun Life Financial Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="Sun Life Financial Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/15/1723558499.png" style="height:265px; width:574px" title="" /></h3>
<p>Sun Life Financial Inc. price-consensus-eps-surprise-chart | Sun Life Financial Inc. Quote</p>
</div>
<h3>Segment Results</h3>
<p><strong>SLF Canada</strong>&#39;s underlying net income increased 8% year over year to $294 million (C$402 million). Canada witnessed solid results at Wealth &amp; Asset Management and Individual - Protection.</p>
<p>Wealth sales &amp; asset management gross flows of $3.6 billion ($5 billion) climbed 72% year over year. Group - Health &amp; Protection increased year over year but Individual - Protection sales declined.</p>
<p><strong>SLF U.S.&#39; </strong>underlying net income was $149 million, which decreased 5% year over year, reflecting soft results at Individual &ndash; Protection and Group - Health &amp; Protection.</p>
<p>U.S. group sales of $243 million decreased 22%, reflecting lower Medicare and Medicaid sales in Dental due to large institutional sales in the prior year, partially offset by higher medical stop-loss sales.</p>
<p><strong>SLF Asset Management </strong>reported underlying net income of $224.3 million (C$307 million), which increased 4% year over year, attributable to stable results in MFS. Asset Management exited the reported quarter with $0.8 trillion (C$1.072 trillion) of AUM, comprising $618 billion in MFS and $165.9 billion (C$227 billion) in SLC Management.</p>
<p><strong>SLF Asia </strong>reported underlying net income of $130.8 million (C$179 million), which grew 19% year over year, driven by solid results at Wealth &amp; asset management and Individual - Protection.</p>
<p>Individual sales of $428 million (C$586 million) jumped 30% year over year. Wealth sales &amp; asset management gross flows of $1.5 billion ($2 billion) increased 24% year over year. New busines</p>
<p>New business CSM of $160.8 million (C$220 million) increased 86.4% year over year, primarily driven by sales in Hong Kong.</p>
<h3>Financial Update &nbsp;</h3>
<p>Global assets under management were $1.1 billion (C$1.465 trillion), up 7% year over year.</p>
<p>Sun Life Assurance&#39;s Life Insurance Capital Adequacy Test (LICAT) ratio was 142% as of Jun 30, 2024, up 300 basis points (bps) from Jun 30, 2023, level.</p>
<p>The LICAT ratio for Sun Life (including cash and other liquid assets) was 150%, which expanded 20 bps year over year.</p>
<p>Sun Life&#39;s return on equity was 11.7% in the second quarter of 2024, which contracted 100 bps year over year. The underlying return on equity of 18.1% expanded 40 bps year over year. The leverage ratio of 22.61% improved 70 bps from Jun 30, 2023, level.</p>
<h3>Dividend Update</h3>
<p>The company&#39;s board of directors approved a quarterly dividend of 81 cents per share. The amount will be paid out on Sep 27, 2024, to shareholders of record at the close of business on Aug 28.</p>
<h3>Zacks Rank</h3>
<p>Sun Life currently carries a Zacks Rank #4 (Sell).</p>
<h3>Performance of Other Insurers</h3>
<p><strong>Voya Financial, Inc</strong>. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voya#NYSE">VOYA</a>) reported second-quarter 2024 adjusted operating earnings of $2.27 per share, which beat the Zacks Consensus Estimate by 3.6%. The bottom line, however, decreased 1.7% year over year. Adjusted operating revenues amounted to $324 million, down 6.6% year over year. The top line missed the Zacks Consensus Estimate by 0.4%.</p>
<p>Net investment income declined 5% year over year to $518 million. Premiums totaled $790 million, up 16.7% from the year-ago quarter. As of Jun 30, 2024, VOYA&#39;s assets under management, assets under administration and advisement totaled $861.3 billion.</p>
<p><strong>Reinsurance Group of America, Incorporated </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) reported second-quarter 2024 adjusted operating earnings of $5.48 per share, which beat the Zacks Consensus Estimate by 10.9%. The bottom line increased 24.5% from the year-ago quarter. RGA&#39;s operating revenues of $5.1 billion improved 20.3% year over year, driven by higher net premiums, investment income, net of related expenses and other revenues. It beat the consensus estimate by 4.7%.</p>
<p>Net premiums of $3.9 billion jumped 17.5% year over year. RGA deployed $307 million for in-force transactions. Investment income and net of related expenses increased 26.3% from the prior-year quarter to $1.1 billion. The average investment yield increased 23 basis points to 4.65%, primarily due to higher new money rates.</p>
<p><strong>Lincoln National Corporation</strong>&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lnc#NYSE">LNC</a>) second-quarter 2024 adjusted earnings of $1.84 per share beat the Zacks Consensus Estimate by 3.4%. However, the bottom line declined 8.9% year over year. Adjusted operating revenues of $4.5 billion dropped 4.3% year over year in the quarter under review. The top line lagged the consensus mark by 2.7%.</p>
<p>Fee income declined 1.9% year over year to $1.3 billion, which missed the Zacks Consensus Estimate by 2.1%. Insurance premiums of $1.6 billion rose 0.8% year over year. The metric beat the consensus mark by 0.7%. LNC&#39;s net investment income of $1.3 billion declined 11.7% year over year and missed the consensus mark by 1.7%. Meanwhile, other revenues fell 5.9% year over year.</p>
<p><a href="https://www.zacks.com/stock/news/2321448/sun-life-slf-q2-earnings-beat-revenues-miss-estimates?cid=CS-BENZ-FT-analyst_blog|earnings_article-2321448">To read this article on Zacks.com click here.</a></p>


VOYA

Sun Life Q2 Earnings Beat, Revenues Miss Estimates

<p>Wells Fargo  analyst Elyse Greenspan   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $236 to $239.</p>


Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $239

<p><strong>Manulife Financial Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mfc#NYSE">MFC</a>) delivered second-quarter 2024 core earnings of 66 cents per share, which beat the Zacks Consensus Estimate by 3.1%. The bottom line improved 6.4% year over year.</p>
<div class="chart_embed">
<p><strong>Manulife Financial Corp Price, Consensus and EPS Surprise</strong></p>
<p><img alt="Manulife Financial Corp Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/52/1723120916.png" style="height:265px; width:577px" title="" /></p>
<p>Manulife Financial Corp price-consensus-eps-surprise-chart | Manulife Financial Corp Quote</p>
<p>Core earnings of $1.3 billion (C$1.7 billion) increased 8.3% year over year. The improvement was driven by continued business growth momentum and updates to actuarial methods and assumptions in the second half of 2023, higher fee income from favorable market impacts and positive net flows, a favorable tax true-up, strong growth in Group Insurance and favorable net insurance experience.</p>
<p>New business value (NBV) in the reported quarter was $528 million (C$723 million), up 21.4% year over year.</p>
<p>New business contractual service margin of $459 million (C$628 million) rose 4.1% year over year.</p>
<p>Annualized premium equivalent (APE) sales increased 16.7% year over year to $1.4 billion (C$1.9 billion), attributable to higher sales in Asia and Canada.</p>
<p>The expense efficiency ratio increased 30 basis points (bps) to 45.4%. The increase reflects a rise of 6% and 7% in pre-tax core earnings and core expenses, respectively.</p>
<p>Wealth and asset management assets under management and administration were $682 billion (C$933.1 billion), up 10.3% year over year.<br />
Retail net outflows of $0.1 billion remained unchanged year over year, as increased demand for investment products amid equity market recovery and improved investor sentiment was offset by higher redemptions.</p>
<p>Core return on equity, measuring the company&#39;s profitability, expanded 20 bps year over year to 15.7%. The financial leverage ratio deteriorated 120 basis points to 24.6% at the end of the quarter.</p>
<p>Life Insurance Capital Adequacy Test ratio was 139% as of Jun 30, 2024, up from 136% reported in the year-ago quarter.</p>
<p>Adjusted book value per common share was $33.96, up 15% year over year.</p>
</div>
<h3>Segmental Performance</h3>
<p>Global Wealth and Asset Management division&#39;s core earnings came in at $291.6 million (C$399 million), up 22.5% year over year.</p>
<p>Asia division&#39;s core earnings totaled $472 million, up 40% year over year. NBV, APE sales and new business CSM increased 19%, 7% and 10%, respectively, year over year, reflecting higher sales volumes in Japan and Hong Kong.</p>
<p>Manulife Financial&#39;s Canada division&#39;s core earnings of $294 million (C$402 million) were up 6.1% year over year. APE sales and NBV increased 61% and 50%, respectively, driven by higher sales volumes in all business units, led by a large-case Group Insurance sale. New business CSM grew 33%, driven by margin expansion in Individual Insurance and higher sales volumes in segregated fund products.</p>
<p>The U.S. division reported core earnings of $303 million, down 11% year over year. APE sales decreased 4% year over year with a shift in product mix, while NBV grew 3%. New business CSM decreased 30% due to a change in product mix and the impact of higher interest rates.</p>
<h3>Zacks Rank</h3>
<p>Manulife Financial currently carries a Zacks Rank #4 (Sell).</p>
<h3>Performance of Other Life Insurers</h3>
<p><strong>Voya Financial, Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voya#NYSE">VOYA</a>) reported second-quarter 2024 adjusted operating earnings of $2.27 per share, which beat the Zacks Consensus Estimate by 3.6%. The bottom line, however, decreased 1.7% year over year. Adjusted operating revenues amounted to $324 million, down 6.6% year over year. The top line missed the Zacks Consensus Estimate by 0.4%.</p>
<p>Net investment income declined 5% year over year to $518 million. Premiums totaled $790 million, up 16.7% from the year-ago quarter. As of Jun 30, 2024, VOYA&#39;s assets under management, assets under administration and advisement totaled $861.3 billion.</p>
<p><strong>Lincoln National Corporation&#39;s</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lnc#NYSE">LNC</a>) second-quarter 2024 adjusted earnings of $1.84 per share beat the Zacks Consensus Estimate by 3.4%. However, the bottom line declined 8.9% year over year. Adjusted operating revenues of $4.5 billion dropped 4.3% year over year in the quarter under review. The top line lagged the consensus mark by 2.7%.</p>
<p>Fee income declined 1.9% year over year to $1.3 billion, which missed the Zacks Consensus Estimate by 2.1%. Insurance premiums of $1.6 billion rose 0.8% year over year. The metric beat the consensus mark by 0.7%. Net investment income of $1.3 billion dipped 11.7% year over year and missed the consensus mark by 1.7%. Meanwhile, other revenues fell 5.9% year over year.</p>
<p><strong>Reinsurance Group of America, Incorporated</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) reported second-quarter 2024 adjusted operating earnings of $5.48 per share, which beat the Zacks Consensus Estimate by 10.9%. The bottom line increased 24.5% from the year-ago quarter. Net foreign currency fluctuations had a favorable effect of 6 cents per share on adjusted operating income compared with the prior year. RGA&#39;s operating revenues of $5.1 billion improved 20.3% year over year, driven by higher net premiums, investment income, net of related expenses and other revenues. It beat the consensus estimate by 4.7%.</p>
<p>Net premiums of $3.9 billion jumped 17.5% year over year. Investment income and net of related expenses increased 26.3% from the prior-year quarter to $1.1 billion. The average investment yield increased 23 basis points to 4.65%, primarily due to higher new money rates. Total benefits and expenses at Reinsurance Group climbed 18.5% year over year to $4.6 billion.</p>
<p><a href="https://www.zacks.com/stock/news/2319430/manulife-mfc-q2-earnings-beat-estimates-nbv-sales-rise-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2319430">To read this article on Zacks.com click here.</a></p>


Manulife Q2 Earnings Beat Estimates, NBV Sales Rise Y/Y

GOCO

OSCR

RELI

SLQT

Shares of insurance companies are trading lower amid overall weakness following concerns for recently issued US economic data.

<p>RBC Capital  analyst Mark Dwelle   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Outperform and raises the price target from $225 to $235.</p>


RBC Capital Maintains Outperform on Reinsurance Gr, Raises Price Target to $235

<p>JP Morgan  analyst Jimmy Bhullar   maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Neutral and raises the price target from $208 to $220.</p>


JP Morgan Maintains Neutral on Reinsurance Gr, Raises Price Target to $220

ALLY

ARES

CRBG

ENVA

HOOD

IBKR

KSPI

LPLA

NCPL

NTRS

PIPR

SOFI

TROW

UPST

VALU

Shares of companies within the broader financial sector are trading lower amid overall market weakness following weak US jobs data.

Piper Sandler analyst John Barnidge maintained a Buy rating on Reinsurance Group (RGA – Research Report) today and set a price target of $237.00. T...

Piper Sandler Keeps Their Buy Rating on Reinsurance Group (RGA)

Fidelity Select Financials Portfolio Q2 2024 Review

Reinsurance Group of America's Rally Can Continue

Tracking William Nygren's Harris Associates Portfolio - Q2 2024 Update

In a report released today, Alex Scott from Barclays maintained a Buy rating on Reinsurance Group (RGA – Research Report), with a price target of $...

Barclays Sticks to Its Buy Rating for Reinsurance Group (RGA)

Piper Sandler analyst John Barnidge maintained a Buy rating on Reinsurance Group (RGA – Research Report) today and set a price target of $242.00. T...

Reinsurance Group (RGA) Gets a Buy from Piper Sandler

KBW analyst Ryan Krueger maintained a Buy rating on Reinsurance Group (RGA – Research Report) today and set a price target of $250.00. The company'...

KBW Remains a Buy on Reinsurance Group (RGA)

In a report released today, Bob Huang from Morgan Stanley maintained a Hold rating on Reinsurance Group (RGA – Research Report), with a price targe...

Morgan Stanley Sticks to Its Hold Rating for Reinsurance Group (RGA)

Insurance brokers a safe bet against Hurricane Milton; reinsurers vulnerable - analysts

U.S. Insurers See Wall Street Rebound After Dire Milton Forecast Blows Over

ACGLN

ACGLO

AFGB

AFGC

AFGD

AFGE

AMZN

BACRP

CBRE

CHTR

CMCSA

CSCO

EWBC

FCFS

FCNCA

GOOG

GOOGL

HTLF

HTLFP

KBWP

KVUE

LBTYK

NDAQ

NVST

OTEX

OXBR

PYPL

SCHW

SPGI

WFCNP

Press Releases

Reinsurance Group of America Announces Pricing of Senior Notes

Reinsurance Group of America to Host Investor Day

AM Best Assigns Issue Credit Rating to Reinsurance Group of America, Incorporated's New Senior Unsecured Notes

Axel André Joins RGA to Succeed Todd Larson as Chief Financial Officer

Reinsurance Group of America Announces Second Quarter Earnings Release Date, Webcast

RGA Leaders of Tomorrow Program Celebrates 10 Years of Inspiring Future Insurance Executives

Reinsurance Group of America Reports Second Quarter Results

RGA Announces $3.5 Billion Coinsurance Transaction with American National Insurance Company

Behavioral Science in Life Insurance Focus of New Study from Society of Actuaries Research Institute

Reinsurance Group of America Announces Third Quarter Earnings Release Date, Webcast

Comments

Reinsurance Gr

Noticias

Últimas noticias sobre Reinsurance Gr (NYSE:RGA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL